home / stock / caba / caba short
Short Information | Cabaletta Bio Inc. (NYSE:CABA)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 20,982 |
Total Actual Volume | 1,196,644 |
Short Trends | |
---|---|
Cover Days | 20 |
Short Days | 0 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 1,049 |
Average Short Percentage | 1.68% |
Is there a CABA Short Squeeze or Breakout about to happen?
See the CABA Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
02-12-2020 | $15.50 | $15.26 | $15.79 | $14.94 | 23,636 | 114 | 0.48% |
02-11-2020 | $15.04 | $15.42 | $15.79 | $14.88 | 33,399 | 111 | 0.33% |
02-10-2020 | $15.39 | $15.05 | $15.89 | $14.88 | 26,717 | 138 | 0.52% |
02-07-2020 | $16.36 | $15.46 | $16.36 | $15.16 | 56,344 | 455 | 0.81% |
02-06-2020 | $16.02 | $16.45 | $16.67 | $15.25 | 56,164 | 12 | 0.02% |
02-05-2020 | $15.30 | $15.94 | $15.94 | $15.16 | 40,603 | 3,403 | 8.38% |
02-04-2020 | $15.45 | $15.28 | $15.8299 | $15.06 | 36,110 | 922 | 2.55% |
02-03-2020 | $16.82 | $15.59 | $16.87 | $15.00 | 124,238 | 211 | 0.17% |
01-31-2020 | $16.93 | $16.43 | $17.70 | $16.27 | 28,963 | 346 | 1.19% |
01-30-2020 | $18.54 | $17.12 | $18.54 | $16.80 | 44,075 | 513 | 1.16% |
01-29-2020 | $16.52 | $18.67 | $19.63 | $16.52 | 97,965 | 5,504 | 5.62% |
01-28-2020 | $17.66 | $16.46 | $17.80 | $16.26 | 43,446 | 207 | 0.48% |
01-27-2020 | $17.47 | $17.63 | $18.00 | $17.47 | 77,333 | 1,315 | 1.7% |
01-24-2020 | $17.22 | $17.47 | $17.99 | $17.12 | 53,874 | 1,074 | 1.99% |
01-23-2020 | $16.35 | $17.15 | $17.7881 | $16.07 | 94,477 | 1,840 | 1.95% |
01-22-2020 | $16.23 | $16.37 | $17.1038 | $15.96 | 49,468 | 562 | 1.14% |
01-21-2020 | $16.28 | $16.17 | $16.625 | $15.90 | 51,014 | 72 | 0.14% |
01-17-2020 | $16.39 | $16.37 | $17.13 | $15.84 | 100,578 | 1,426 | 1.42% |
01-16-2020 | $16.07 | $16.27 | $16.7755 | $15.62 | 81,419 | 1,824 | 2.24% |
01-15-2020 | $15.33 | $16.00 | $16.19 | $14.53 | 76,821 | 933 | 1.21% |
News, Short Squeeze, Breakout and More Instantly...
PHILADELPHIA, July 02, 2024 (GLOBE NEWSWIRE) -- Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology company focused on developing and launching the first curative targeted cell therapies designed specifically for patients with autoimmune diseases, today announced that Steven Nichtb...
2024-06-20 09:56:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
– No CRS, ICANS, infections or serious adverse events observed in either of the first two patients through data cut-off of May 28, 2024 – – CABA-201 exhibited anticipated profile of CAR T cell expansion and contraction with complete B cell depletion observed in both...